Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques

An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers

(2011) Eva Van Braeckel et al.   CLINICAL INFECTIOUS DISEASES

Early Target Cells of Measles Virus after Aerosol Infection of Non-Human Primates

(2011) Ken Lemon et al.   PLoS Pathogens

Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

(2010) E. Galanis et al.   CANCER RESEARCH

Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination

(2010) M. Juliana McElrath et al.   IMMUNITY

CD147/EMMPRIN Acts as a Functional Entry Receptor for Measles Virus on Epithelial Cells

(2010) A. Watanabe et al.   JOURNAL OF VIROLOGY

In Vivo Tropism of Attenuated and Pathogenic Measles Virus Expressing Green Fluorescent Protein in Macaques

(2010) R. D. de Vries et al.   JOURNAL OF VIROLOGY

Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses

(2009) Matthias Liniger et al.   VACCINE

Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160ΔV1V2 is strongly immunogenic

(2009) Mathilde Guerbois et al.   VIROLOGY

Transduction Properties of Adenovirus Serotype 35 Vectors After Intravenous Administration Into Nonhuman Primates

(2008) Fuminori Sakurai et al.   MOLECULAR THERAPY

The Pathogenesis of Measles Revisited

(2008) Rik L. de Swart   PEDIATRIC INFECTIOUS DISEASE JOURNAL